» Articles » PMID: 37273755

Primary Intra‑abdominal Desmoid Fibromatosis Associated with Familial Adenomatous Polyposis: A Case Report

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2023 Jun 5
PMID 37273755
Authors
Affiliations
Soon will be listed here.
Abstract

Desmoid fibromatosis (DF) is a clonal proliferative disorder of myofibroblasts, which arises, with a low incidence, in soft tissue, including within the abdomen. The incidence of DF is associated with familial adenomatous polyposis (FAP), and is more common following FAP surgery. It is rare for a patient to make his/her first visit to hospital due to DF symptoms associated with FAP. In the present report, a case of mesenteric DF associated with FAP is described. This case also had incomplete intestinal obstruction due to DF. By summarizing previous studies examining DF and FAP treatment, combined with the disease characteristics of this patient, the clinical treatment strategy for DF associated with FAP was explored.

References
1.
Rutenberg M, Indelicato D, Knapik J, Lagmay J, Morris C, Zlotecki R . External-beam radiotherapy for pediatric and young adult desmoid tumors. Pediatr Blood Cancer. 2011; 57(3):435-42. DOI: 10.1002/pbc.22916. View

2.
He X, Zhang Y, Wang L, Tian M, Liu W, Qu Q . Prognostic factors for the recurrence of sporadic desmoid-type fibromatosis after macroscopically complete resection: Analysis of 114 patients at a single institution. Eur J Surg Oncol. 2015; 41(8):1013-9. DOI: 10.1016/j.ejso.2015.04.016. View

3.
Roussin S, Mazouni C, Rimareix F, Honore C, Terrier P, Mir O . Toward a new strategy in desmoid of the breast?. Eur J Surg Oncol. 2015; 41(4):571-6. DOI: 10.1016/j.ejso.2015.01.001. View

4.
Righetti A, Jacomini C, Parra R, Almeida A, Rocha J, Feres O . Familial adenomatous polyposis and desmoid tumors. Clinics (Sao Paulo). 2011; 66(10):1839-42. PMC: 3180149. DOI: 10.1590/s1807-59322011001000027. View

5.
Bonvalot S, Eldweny H, Haddad V, Rimareix F, Missenard G, Oberlin O . Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients. Eur J Surg Oncol. 2007; 34(4):462-8. DOI: 10.1016/j.ejso.2007.06.006. View